Related Experiment Videos
Role of inflammatory mediators in thrombogenesis
Ronald J Shebuski1, Kenneth S Kilgore
1CarePoint Diagnostics, Inc., Eden Prairie, Minnesota 55344, USA. CVR2000@portup.com
The Journal of Pharmacology and Experimental Therapeutics
|February 28, 2002
Summary
Inflammation drives cardiovascular disease by increasing tissue factor (TF) and P-selectin. These molecules interact to accelerate blood clot formation, highlighting potential therapeutic targets.
Area of Science:
- Cardiovascular Biology
- Inflammation Research
- Thrombosis
Background:
- Inflammation is increasingly recognized as a key factor in cardiovascular disease and thrombogenesis.
- Plaque rupture triggers inflammatory responses and tissue factor (TF) expression, initiating coagulation.
- Proinflammatory cytokines regulate TF expression on endothelial cells, smooth muscle cells, and monocytes.
Purpose of the Study:
- To review the role of cytokines in mediating TF expression.
- To explore the significance of the P-selectin and TF relationship in thrombus generation.
- To discuss potential pharmacological interventions targeting this process.
Main Methods:
- Literature review focusing on inflammation, TF, and P-selectin in cardiovascular disease.
- Analysis of the interaction between TF, P-selectin, and PSGL-1 in coagulation.
- Discussion of clinical relevance in acute coronary syndromes.
Main Results:
- TF initiates extrinsic coagulation, and its expression is cytokine-regulated.
- P-selectin accelerates fibrin formation and deposition through interaction with TF and PSGL-1.
- Soluble P-selectin levels are elevated in acute coronary syndromes.
Conclusions:
- Cytokines play a crucial role in TF-mediated thrombogenesis.
- The interplay between P-selectin and TF is significant in thrombus generation.
- Targeting these pathways offers potential therapeutic strategies for cardiovascular disease.